Embassy Developments NCLAT stay continues: April 10, 2026

What the company disclosed and why it matters

Embassy Developments Limited has updated stock exchanges on an ongoing matter before the National Company Law Appellate Tribunal (NCLAT), Principal Bench, New Delhi. The update follows a hearing held on March 19, 2026, in proceedings related to a Corporate Insolvency Resolution Process (CIRP). The company said the NCLAT has kept in force its stay on the National Company Law Tribunal (NCLT) order that had admitted the CIRP.

For investors and counterparties, the key point is that the NCLT admission order remains inoperative for now. With the stay continuing, the insolvency process that would otherwise move forward at the NCLT level is effectively on hold. The next listed date is April 10, 2026, when the matter is scheduled for submissions on behalf of the Respondents and further proceedings.

March 19 hearing: adjournment granted with a warning

According to the company’s disclosure, the matter relating to the stay order was heard by the Hon’ble NCLAT on March 19, 2026. During the hearing, counsel representing the Respondent sought an adjournment. The Tribunal granted the request.

However, the Tribunal also recorded an explicit observation: no further adjournment shall be sought by the Respondents. That direction is relevant because repeated adjournments can extend timelines in appellate litigation and keep the underlying dispute unresolved for longer.

Embassy Developments said the case is now listed on April 10, 2026 for Respondents’ submissions and further proceedings.

What is stayed: the NCLT order admitting CIRP

Embassy Developments also confirmed that the impugned order passed by the Hon’ble NCLT, which had admitted the CIRP, continues to remain stayed by the NCLAT. In practical terms, the company stated that the NCLT order is presently inoperative, and proceedings arising from it are stayed.

The disclosure focuses on procedural status rather than the merits of the dispute. It does not provide fresh details on the claims in the underlying insolvency case, but it clearly reiterates that the appellate stay remains in place.

Next date: April 10, 2026, for Respondents’ submissions

The company has pointed stakeholders to April 10, 2026 as the next key date. The matter has been listed for submissions on behalf of the Respondents and for further proceedings.

The NCLAT’s note that no further adjournment shall be sought by the Respondents indicates the Tribunal expects the Respondents to proceed with their arguments on the next date. Beyond that, the company has not indicated any scheduled dates after April 10.

How this matter has progressed through earlier adjournments

The company’s update sits within a sequence of hearings and adjournments described in earlier disclosures and summaries included in the source text. The matter was previously listed on February 19, 2026 but could not be taken up and was adjourned to February 27, 2026. On February 27, 2026, the Tribunal heard submissions from the company’s counsel and treated the matter as part-heard, scheduling continuation on March 13, 2026.

On March 13, 2026, the company’s submissions and arguments were stated to have been completed, and an adjournment was granted to the Respondents for additional time to complete their arguments, moving the matter to March 19, 2026. The March 19 hearing again resulted in an adjournment, and the next date is now April 10, 2026.

Timeline of key hearing dates and current status

Company’s operational position as stated in the update

The source text states that Embassy Developments has asserted it remains fully operational and financially sound while the appellate process continues. The company’s disclosures position the continuing stay as enabling business continuity by keeping the CIRP admission order inoperative, at least until the NCLAT hears further submissions and passes subsequent directions.

This is an important distinction for market participants: the legal process remains active, but the specific step that would formally trigger CIRP consequences is currently stayed.

Financial and market context mentioned in the source text

Beyond the legal timeline, the source text also includes additional context on the company’s numbers and market positioning. It states that the company’s net sales fell 56.93% quarter-on-quarter to ₹212.40 crore. It also states that promoters have pledged 47.8% of their holding.

The same text mentions that the share price fell 54.78% over the past year, and that the stock exchanges placed the company under the ‘Additional Surveillance Measure’ (ASM) framework and the ‘BE’ segment. It also mentions that promoters recently raised ₹1,160 crore, and separately references a ₹400 crore project receiving RERA approval for an Alibaug project named “Embassy Serenity”.

Market impact: what the continuing stay changes, and what it does not

The continuing NCLAT stay keeps the NCLT’s CIRP admission order inoperative and suspends related proceedings arising from that order. That reduces immediate process-driven disruption that could otherwise follow from an active CIRP admission order.

At the same time, the matter remains before the appellate forum, and the next step is the Respondents’ submissions on April 10, 2026. The company’s update is therefore mainly a status report: it confirms the current legal position and the next date of hearing, rather than signalling a final resolution.

Analysis: why the April 10 date is a key checkpoint

The NCLAT’s observation that no further adjournment shall be sought by the Respondents makes the April 10 hearing a clearer checkpoint than prior dates that ended in postponements. Procedurally, it suggests the Tribunal wants the Respondents to complete their submissions so the matter can move ahead.

The case also sits against a backdrop of investor sensitivity to insolvency-related proceedings, promoter pledges, and sharp changes in reported sales figures. In that context, each procedural update on whether the stay continues, and how quickly the appeal progresses, can influence how stakeholders assess near-term uncertainty.

Conclusion

Embassy Developments has informed exchanges that the NCLAT hearing on March 19, 2026 was adjourned at the Respondents’ request, with the Tribunal noting no further extensions should be sought. The matter is listed on April 10, 2026 for Respondents’ submissions, while the NCLT order admitting CIRP remains stayed and inoperative. The next confirmed milestone is the April 10, 2026 listing before the NCLAT.